Revenue is meaningless when you aren't turning enough profit to manage your toxic debt. Liabilities also exceed assets by a good bit here. These deals they made with note holders were VERY bad for shareholders. Most are similar to this one
On August 30, 2018, the Company entered into a variable convertible note for $337,500 with net proceeds of $303,750. The note is due February 28, 2019 and bears interest at 10% per annum. The note is immediately convertible into shares of the Company's Class A common stock at a discount of 42% to the average of the two lowest trading closing prices of the stock for ten days prior to conversion. This note is currently past due.
Last year I thought the stock looked really good at .10 and didn't understand why it was trading so low. Now it's at .0075